Studies on Transgenic Mice with Loss- or Gain-in-Function in the Sh3bp2 Gene Corroborate Importance of SH3BP2 Signalosome in Nephrotic Syndrome
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Immunopathogenesis of Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) remains unclear. We reported upregulated scaffold protein SH3BP2 signaling in glomerular transcriptome in MCD and FSGS. Mice with a gain-in-function mutation (Sh3bp2KI/KI) presented increased innate immune activity with features of nephrotic syndrome (JCI Insight 2024:e170055). Here, we compared the effect of Sh3bp2 gene deletion (Sh3bp2 -/-) vis-a-vis Sh3bp2KI/KI mice. Methods: Sh3bp2 +/+, Sh3bp2-/- and Sh3bp2KI/KI mice (4 and 12wks) were used to determine changes in albuminuria, serum albumin and creatinine (n=10-12/group), serum cytokines (Luminex Multiplex) and peripheral blood cells (flow cytometry) and podocyte ultrastructure (EM). Differences expressed at p<0.05. Results: Bodyweight, but not kidney weight, was lower in Sh3bp2KI/KIcompared to Sh3bp2 +/+ or Sh3bp2 -/- at 4- and 12-wks, Albuminuria was higher in Sh3bp2KI/KIcompared to Sh3bp2 +/+ or Sh3bp2 -/- at 4- and 12-wks with hypoalbuminemia in Sh3bp2KI/KIat 12wks (Fig. 1). Serum creatinine was comparable between groups. Sh3bp2KI/KI mice showed decreased number of slits/length (EM). Sh3bp2KI/KI (12 wks) showed increased macrophages and double negative T-cells (CD3+CD4-CD8-) and decreased NKT cells and unchanged B-cells and innate lymphoid cells (IL). Cytokines showing increase in Sh3bp2KI/KI but not in Sh3bp2-/- and Sh3bp2+/+ mice were: TNFSF13B, Eotaxin, YKL-40, CXCL1, GDF-15, ICAM-1, IL-16, LDLR, TIMP-1, MCP-1, G-CSF, IL-1ra, MIP-1α, CXCL10, RANTES, IL-1β and TNFαa. LIX and MCSF increased in both Sh3bp2KI/KIand Sh3bp2-/- but not in Sh3bp2+/+ mice. Conclusion: Lack of changes in Sh3bp2-/- mice supports previous findings suggesting the significance of increased SH3BP2 protein in immunopathogenesis of nephrotic syndrome. Funding: Other U.S. Government SupportThe figure shows the albuminuria, serum albumin, serum creatinine, slits per length of GBM on EM and immune cells on flow cytometry.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Studies on Transgenic Mice with Loss- or Gain-in-Function in the Sh3bp2 Gene Corroborate Importance of SH3BP2 Signalosome in Nephrotic Syndrome
- Date Crossref
- 01/10/2025
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.